These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 310951)

  • 1. Cefamandole: a new cephalosporin for therapy of hospitalized patients with infection.
    Meyers BR; Wormser G; Gartenberg G; Nicholas P; Hirschman SZ
    Mt Sinai J Med; 1978; 45(6):722-8. PubMed ID: 310951
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of serious skin and soft tissue infections with cefamandole.
    Glanges E; Webber CE; Crenshaw CA; Pasquet M; Barksdale L
    Scand J Infect Dis Suppl; 1980; suppl 25():69-74. PubMed ID: 7010539
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].
    Di Nola F; Eandi M; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Robecchi GA
    Minerva Med; 1980 May; 71(21):1515-24. PubMed ID: 7383410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infection prophylaxis with cefamandole. Clinical evaluation in the open heart-surgery and the prosthetic vascular reconstruction (author's transl)].
    Tschirkov A; Eigel P
    Med Klin; 1979 Apr; 74(17):672-4. PubMed ID: 440193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefamandole--effectiveness against anaerobes: supplementary remarks.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():94-5. PubMed ID: 7010543
    [No Abstract]   [Full Text] [Related]  

  • 6. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.
    Gentry LO; Wood BA; Martin MD; Smythe J
    Scand J Infect Dis Suppl; 1980; suppl 25():96-100. PubMed ID: 7010544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefamandole in the treatment of serious bone and joint diseases.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 9. Cefamandole and cefoxitin.
    Med Lett Drugs Ther; 1979 Feb; 21(3):13-5. PubMed ID: 310945
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of serious anaerobic infections.
    Greenberg RN; Scalcini MC; Sanders CV; Lewis AC
    Scand J Infect Dis Suppl; 1980; suppl 25():84-8. PubMed ID: 7010541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience with the newest cephalosporins].
    Graber H; Arr M; Ludwig E; Magyar T; Ternovszky E
    Orv Hetil; 1984 Jan; 125(4):211-5. PubMed ID: 6694841
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical and bacteriologic evaluation of cefamandole therapy in serious skin and skin structure infections.
    Glanges E; Crenshaw CA; Webber CE
    Surg Gynecol Obstet; 1980 Apr; 150(4):502-6. PubMed ID: 7361234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftizoxime compared with cefamandole for treatment of soft tissue infections.
    Mills J; Slutkin G; Klein D; Schecter W
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():273-9. PubMed ID: 6296020
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of cefamandole in the treatment of soft tissue and skeletal infections.
    LeFrock JL; Paparone P; Kowalsky SF; Schell RF; Jacobs RL; Wirth CR; Tillotson JR
    Drug Intell Clin Pharm; 1981 Dec; 15(12):951-7. PubMed ID: 7338190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of cefepime in the treatment of serious bacterial infections in hospitalized adult patients.
    Sheng WH; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2000 Jun; 33(2):109-14. PubMed ID: 10917881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefamandole in the treatment of soft tissue infections.
    Ramírez-Ronda CH; Quiñones-Soto R; Lugo-Velázquez A; Bermúdez RH
    Chemotherapy; 1982; 28(3):224-8. PubMed ID: 7094663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefamandole for treatment of obstetrical and gynecological infections.
    Cunningham FG; Gilstrap LC; Kappus SS
    Scand J Infect Dis Suppl; 1980; suppl 25():75-82. PubMed ID: 7010540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial pneumonia in the elderly: a reappraisal of conventional therapy, with a note on cefamandole.
    Gleckman RA; Esposito AL
    J Am Geriatr Soc; 1979 Aug; 27(8):345-7. PubMed ID: 458085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, double blind study of preventive cefamandole therapy in patients at high risk for undergoing cholecystectomy.
    Crenshaw CA; Glanges E; Webber CE; McReynolds DB
    Surg Gynecol Obstet; 1981 Oct; 153(4):546-52. PubMed ID: 7025307
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefamandole nafate: an evaluation of antibacterial activity, serum levels, clinical effect, and incidence of side reactions in 58 patients.
    Ekwall E; Holmgren EB; Lundbergh P; Svanbom M; Tunevall G
    Scand J Infect Dis; 1979; 11(2):135-9. PubMed ID: 462128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.